Next-Generation Pharmacovigilance
Interdisciplinary Journal of the African Alliance for Research, Advocacy and Innovation · 03.04.2026 · 2 (2)
DOI: 10.64261/x8f2hr74 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interdisciplinary Journal of the African Alliance for Research, Advocacy and Innovation, online erschienen am 03.04.2026. Verfasst von Viqaz Arshad und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The increase in the size and complexity of drug safety information is increasingly pushing the traditional pharmacovigilance systems towards failure in timely detecting adverse drug reactions, as well as ineffective signal identification. Machine learning (ML) and artificial intelligence can bring revolutionary prospects to advance drug safety monitoring with its automated data processing, recognition of the patterns, and predictive analytics. The review focuses on the assessment of existing AI and ML uses, advantages, and drawbacks in pharmacovigilance. PubMed, Scopus, and Web of Science were selected as the databases that underwent a systematic literature search of the publications published between 2020 and 2025 using the following key words as pharmacovigilance, AI, ML, ADRs, and drug safety monitoring. Relevant publications have been analyzed to determine the important technological methods, regulatory factors, and barriers to the implementation. The AI-based systems show a high level of enhancement in ADR detection rates, signal control, and automatic processing of cases. The practicality of natural Text analysis for extraction safety data in unstructured clinical stories and social media and the ability of Ml-based models to improve predictive risk stratification were demonstrated. Deep-learning solutions have specific potential in the use of electronic health records and real-world evidence. There are still issues of data standardization, transparency of the algorithms, compliance with the regulation, and integration with the current workflows. The adoption should be accompanied by sound validation structures and alignment with changing regulatory rules to succeed.
Zitieren
APA
Arshad, V., Haq, S. I. U., Malik, S. H., & Ashraf, R. (2026). Next-Generation Pharmacovigilance. Interdisciplinary Journal of the African Alliance for Research, Advocacy and Innovation, 2(2). https://doi.org/10.64261/x8f2hr74
Vancouver
Arshad V, Haq SIU, Malik SH, Ashraf R. Next-Generation Pharmacovigilance. Interdisciplinary Journal of the African Alliance for Research, Advocacy and Innovation. 2026;2(2). doi:10.64261/x8f2hr74
BibTeX
@article{Arshad2026,
author = {Arshad, Viqaz and Haq, Sheikh Irshad Ul and Malik, Shafkat Hussain and Ashraf, Ruhit},
title = {Next-Generation Pharmacovigilance},
journal = {Interdisciplinary Journal of the African Alliance for Research, Advocacy and Innovation},
year = {2026},
volume = {2},
number = {2},
doi = {10.64261/x8f2hr74}
}
EUVIMED